MedPath

I.M. Sechenov First Moscow State Medical University

I.M. Sechenov First Moscow State Medical University logo
🇷🇺Russia
Ownership
Private
Established
1758-01-01
Employees
5K
Market Cap
-
Website
http://www.mma.ru

Clinical Trials

115

Active:8
Completed:60

Trial Phases

6 Phases

Early Phase 1:1
Phase 1:2
Phase 2:3
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (79 trials with phase data)• Click on a phase to view related trials

Not Applicable
65 (82.3%)
Phase 4
7 (8.9%)
Phase 2
3 (3.8%)
Phase 1
2 (2.5%)
Early Phase 1
1 (1.3%)
Phase 3
1 (1.3%)

Gas Composition in the Hypopharynx During High-flow or Standard Oxygen Therapy Through Face Mask in Healthy Volunteers

Not Applicable
Not yet recruiting
Conditions
Healthy Volunteers
First Posted Date
2025-06-13
Last Posted Date
2025-06-13
Lead Sponsor
I.M. Sechenov First Moscow State Medical University
Target Recruit Count
10
Registration Number
NCT07019701
Locations
🇷🇺

Sechenov University Clinic#4, Moscow, Russian Federation

Staging Heart Failure With Preserved Ejection Fraction

Not yet recruiting
Conditions
Heart Failure With Preserved Ejection Fraction
Cardiovascular Diseases
Heart Failure
First Posted Date
2025-04-16
Last Posted Date
2025-04-20
Lead Sponsor
I.M. Sechenov First Moscow State Medical University
Target Recruit Count
700
Registration Number
NCT06931015
Locations
🇷🇺

A Shchendrygina, Moscow, Russian Federation

Treatment Hypertension to Recommended Levels in Old Patients

Not Applicable
Conditions
Arterial Hypertension
First Posted Date
2025-03-10
Last Posted Date
2025-03-10
Lead Sponsor
I.M. Sechenov First Moscow State Medical University
Target Recruit Count
60
Registration Number
NCT06865846
Locations
🇷🇺

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), University Clinical Hospital No.1, Russian Gerontological Scientific and Clinical Center, Moscow, Russian Federation

Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction

Not Applicable
Recruiting
Conditions
Bacterial Overgrowth Syndrome Small Bowel
Heart Failure with Preserved Ejection Fraction
Interventions
Other: Standard HFpEF treatment
First Posted Date
2024-10-22
Last Posted Date
2024-10-22
Lead Sponsor
I.M. Sechenov First Moscow State Medical University
Target Recruit Count
40
Registration Number
NCT06652087
Locations
🇷🇺

Moscow, Moscow, Russian Federation

Remote Multichannel Monitoring of Patients With Chronic DIseAses Using Speech technoLogies Based On Artificial intelliGence

Not Applicable
Not yet recruiting
Conditions
Heart Failure
Diabetes Mellitus
Arterial Hypertension
Lymphoproliferative Disease
Total Knee Replacement
First Posted Date
2024-10-16
Last Posted Date
2024-10-16
Lead Sponsor
I.M. Sechenov First Moscow State Medical University
Target Recruit Count
500
Registration Number
NCT06644339
Locations
🇷🇺

Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), University Clinical Hospital No.1, Moscow, Russian Federation

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 23
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath